Unadjusted outcomes after admission for cardiac device infection; (+) COVID-19, infected with COVID-19 virus; (-) COVID-19, non-infected with COVID-19 virus. by Nameer Ascandar (15449218)

Subjects:

Unadjusted outcomes after admission for cardiac device infection during and prior to the COVID-19 pandemic. by Nameer Ascandar (15449218)

Subjects:

Baseline patient, clinical, and hospital factors after admission for cardiac device infection; (+) COVID-19, infected with COVID-19; (-) COVID-19, not infected with COVID-19. by Nameer Ascandar (15449218)

Subjects:

Factors associated with adjusted odds of major adverse events after admission for cardiac device infection; *<i>P<0</i>.<i>05</i>. by Nameer Ascandar (15449218)

Subjects:

Venn diagram illustrating volume distribution of device removal. by Nameer Ascandar (15449218)

Subjects:

Joinpoint trends in age-standardized mortality rates for the major female-specific cancers by race and ethnicity in the United States, 2000–2022. by Ze Zhang (47230)

Subjects:

Trends in annual age-standardized rates for six major female-specific cancers mortality (2000–2022) by race and ethnicity in the USA. by Ze Zhang (47230)

Subjects:

Trends in annual age-standardized rates for six major female-specific cancers incidence (2000-2021) by race and ethnicity in the USA. by Ze Zhang (47230)

Subjects:

Joinpoint trends in age-standardized incidence rates for the major female-specific cancers by race and ethnicity in the United States, 2000–2021. by Ze Zhang (47230)

Subjects:

Robustness test of the Heckman two-stage estimation method. by Caihong Wen (17904307)

Model estimates and significance levels from linear mixed-effect models of ECM root tip colonization. by Laura García de Jalón (8939456)

The results of estimation and verification of the trend models for the processes <i>Y</i>_<i>t</i> and <i>X</i>_<i>t</i>. by Tomasz Grodzicki (3130218)

Subjects:

Models 7 to 12: estimation results. by Sakar Hasan Hamza (20978818)

Models 1 to 6: estimation results. by Sakar Hasan Hamza (20978818)

Mortality rates per lifecycle stage [28]. by Albertus Constantijn Sloof (20405090)

“…Implementing rapid vaccination after detecting the virus in ten individuals and achieving 40% coverage could reduce infection rates by 82%, preventing 139,805 cases. Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …”

Posterior estimates of niche overlap for predators. by Nathan D. McTigue (10706460)

Means and standard error of daily growth rates of Atlantic sea scallops, <i>Placopecten magellanicus</i> over an 8-week exposure to different CO₂ enrichment levels (low,... by Emilien Pousse (14664318)

Subjects:

Trends in age-standardized death rates attributable to specific risk factors for four major female-specific cancers incidence (2000–2021) in the USA. by Ze Zhang (47230)

Subjects:

Effect sizes (posterior estimates) for the best-fit models testing the response of detection rate to the climate variables. by Maldwyn John Evans (17061173)

Sequence-based estimation of (A) peptide charges and (B) hydrophobicity index. K12 E. coli strains express the (I, α) allele, which is bolded here for reference. by Chunyu Liao (4436998)

Subjects: